Medical therapy of gastroesophageal reflux. Evaluation of the activity of clebopride by continuous intraluminal pH measurement
Alvisi, V.; Onofrio, W.; Intrieri, L.; D'Ambrosi, A.
Minerva Medica 78(19): 1421-1426
1987
ISSN/ISBN: 0026-4806 PMID: 3670685 Document Number: 293649
Seven female and three male outpatients (mean age 45, range 37-54), suffering from gastroesophageal reflux underwent therapy with clebopride, a new selective antidopaminergic agent. Before and after treatment (1 mg b.i.d. for ten days) 24 h-continuous monitoring of esophageal pH was done. Clebopride significantly lowered the number and the extension of gastroesophageal acid refluxes.